Demographic and Treatment Variability of Refractory Kawasaki Disease: A Multicenter Analysis
نویسندگان
چکیده
ABBREVIATIONS IQR: interquartile range IVIG: intravenous immunoglobulin KD: Kawasaki disease PHIS: Pediatric Health Information System rKD: refractory Kawasaki disease sKD: standard Kawasaki disease www.hospitalpediatrics.org doi:10.1542/hpeds.2011-0011-2 Dr Ghelani was responsible for the study design, data collection, interpretation of data, statistical analysis, and manuscript writing; Mr Pastor was responsible for data collection, interpretation of data, and review of the manuscript; and Dr Parikh was responsible for study concept and design, interpretation of data, and review of the manuscript. Address correspondence to Kavita Parikh, MD, Pediatric Hospitalist Faculty, Children’s National Medical Center, Assistant Professor of Pediatrics, The George Washington University Medical Center, 111 Michigan Ave NW, Suite 4800, Washington DC 20010. E-mail: kparikh@ cnmc.org HOSPITAL PEDIATRICS (ISSN Numbers: Print, 0031 4005; Online, 1098 4275). Copyright © 2012 by the American Academy of Pediatrics
منابع مشابه
Demographic and treatment variability of refractory kawasaki disease: a multicenter analysis from 2005 to 2009.
OBJECTIVE Approximately 10% to 15% of Kawasaki disease (KD) is refractory to treatment with initial intravenous immunoglobulin (IVIG). However, there is no consensus on pharmacologic treatment of refractory KD (rKD). Demographic characteristics of patients with rKD and regional variability in their treatment in the United States have not been reported on a large scale. The goal of this study wa...
متن کاملUse of Corticosteroid in Children with Unresponsiveness to Intravenous Immunoglobulin in Kawasaki Disease
Background Kawasaki Disease (KD) is a vasculitis with multi-organ involvementof unknown etiology; it is the most common cause of pediatric-heart diseases in developed countries. Treatment with Intravenous Immunoglobulin (IVIG) prevents coronary artery lesions; although there are some IVIG-resistant cases, combination therapy with corticosteroids and IVIG is one of the recommendations for treatm...
متن کاملEpidemiological and Clinical Characteristics of Kawasaki Disease in Mazandaran
Background and purpose: Kawasaki is an acute childhood vasculitis of unknown cause that if left untreated can cause coronary aneurysms in 25% of cases. The disease is reported as the leading cause of acquired heart disease in children in developed countries. The purpose of this study was to investigate the epidemiological and clinical features of Kawasaki disease in northern Iran. Materials an...
متن کاملInfliximab Treatment for Refractory Kawasaki Disease in Korean Children
BACKGROUND AND OBJECTIVES This was a multicenter study to evaluate the usefulness of the tumor necrosis factor-alpha (TNF-alpha) blocker infliximab for treatment of Korean pediatric patients with refractory Kawasaki disease (KD). SUBJECTS AND METHODS Data from 16 patients throughout Korea who were diagnosed with refractory KD and received infliximab were collected retrospectively. RESULTS C...
متن کاملComparison of early and late intravenous gamma globulin treatment of Kawasaki disease on fever and cardiovascular complications
Background: Cardiac involvement was the major leading cause of death in patients with Kawasaki and IVIG administration reduces cardiac complications. The objective of this study was to determine the frequency of cardiovascular complications and duration of fever with regard to the time of intravenous immunoglobulin (IVIG) administration of patients with Kawasaki disease. Methods: This follow...
متن کامل